General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.

A series of constrained ketone-based inhibitors has been developed that show low nanomolar Ki values. These ketone inhibitors showed promising activity towards cruzain, the cysteine protease implicated in Chagas' disease. This series of constrained inhibitors, which can be accessed quickly and efficiently using a solid-phase combinatorial strategy, should be applicable to other members of the cysteine protease class.

[1]  T. Schirmeister,et al.  Cysteine Proteases and Their Inhibitors. , 1997, Chemical reviews.

[2]  J. Palmer,et al.  Vinyl sulfones as mechanism-based cysteine protease inhibitors. , 1995, Journal of medicinal chemistry.

[3]  R. Smith,et al.  Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases. , 1991, Biochemistry.

[4]  J. McKerrow,et al.  Cysteine protease inhibitors as chemotherapy for parasitic infections. , 1999, Bioorganic & medicinal chemistry.

[5]  D. Fairlie,et al.  Protease inhibitors: current status and future prospects. , 2000, Journal of medicinal chemistry.

[6]  S. L. Gwaltney,et al.  Vinyl Sulfonate Esters and Vinyl Sulfonamides: Potent, Irreversible Inhibitors of Cysteine Proteases , 1998 .

[7]  C. Craik,et al.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Y. Ru,et al.  Cyclic ketone inhibitors of the cysteine protease cathepsin K. , 2001, Journal of medicinal chemistry.

[9]  G. H. Coombs,et al.  Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi. , 1994, FEMS microbiology letters.

[10]  Y. Ru,et al.  Azepanone-based inhibitors of human and rat cathepsin K. , 2001, Journal of medicinal chemistry.

[11]  D. Mcnulty,et al.  Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.

[12]  J. McKerrow.  Cysteine proteases of parasites: A remarkable diversity of function , 1995 .

[13]  J. McKerrow,et al.  Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection , 1998, Journal of Experimental Medicine.

[14]  N. Thornberry.  Caspases: key mediators of apoptosis. , 1998, Chemistry & biology.

[15]  P. Rosenthal,et al.  The proteases and pathogenicity of parasitic protozoa. , 1993, Annual review of microbiology.

[16]  J. Morrison,et al.  [17] The kinetics of reversible tight-binding inhibition , 1979 .

[17]  J. Ellman,et al.  Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis. , 2002, Journal of medicinal chemistry.

[18]  J. Scharfstein,et al.  Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. , 1992, Molecular and biochemical parasitology.